Kristin R. Anfinson
Papers
2
Total Citations
40
H-Index
2
About
Dr. Kristin R. Anfinson is pioneering the automation of stem cell manufacturing to unlock the future of regenerative medicine, particularly for treating inherited retinal degeneration. Her research focuses on developing high-throughput, reproducible systems for generating and handling human induced pluripotent stem cells (hiPSCs). In her landmark 2023 paper, "Automating iPSC generation to enable autologous photoreceptor cell replacement therapy" (30 citations), she directly addresses a critical bottleneck in cell therapy: the lack of commercial technologies for parallel production of patient-specific cells. This work lays the foundation for scalable, autologous photoreceptor replacement, offering hope for the millions facing incurable vision loss. Complementing this, her work on "Automated human induced pluripotent stem cell colony segmentation" (10 citations) introduces machine learning-driven quality control for clinical-grade cell culture. By integrating robotics and AI, Dr. Anfinson is not just advancing lab techniques; she is building the manufacturing infrastructure necessary to make personalized cell therapies a practical, clinical reality, with profound implications for ophthalmology and beyond.
Research Focus
Key Achievements
Top Papers
- 1
- 2